“For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law. According to a just published review in the German scientific journal Deutsches Ärzteblatt International, scientific findings from over 100 controlled clinical trials involving either cannabis or its constituents provide ‘clear evidence that cannabinoids are useful for the treatment of various medical conditions.'”
Related posts:
"Undecided" House Members Who Need Phone Calls to Vote No on Syria Attack
Fast food workers stage surprise strike in New York City
Interpol proposes new solution to shootings, terrorism: ‘Arm civilians’
Cryptocurrencies Gaining Popularity in India’s Major Cities
IRS FBAR forms no longer accepted by postal mail
Lawmakers Vote to Let Obama Take Your Passport Without Trial
Flood of Teenage Immigrants? The DHS's Solution: ID Card Compliance
Gallup Poll Finds 58% of Americans Support Legalizing Marijuana
Thousands Of Firms Trade Confidential Data With The US Government In Exchange For Classified Intelli...
Fiscal Cliff Deal: $1 in Spending Cuts for Every $41 in Tax Increases
Introducing the Ross Ulbricht Legal Defense Fund
Deutsche Bank Exits Commodity Trading, Fires 200
The Incredible Shrinking Computer
CurrencyFair Suspends Foreign Exchange Service for US Customers
Scientists say ‘robot boy’ can be built within nine months